International Introduction of GMP Oligonucleotides for IVD and ASR Applications by Eurofins Genomics
Eurofins Genomics has introduced its good manufacturing practices (GMP) oligonucleotide offerings across Europe for in-vitro...
Pharmacogenetic and pharmacogenomic analysis of the effects of pharmaceutical compounds helps to realise the concept of individualised drug therapy or personalised medicine.
While pharmacogenetics describes genetic variations between individuals and their influence on the efficacy and side effects of drugs, pharmacogenomics examines interactions of drugs with the whole genome: changes of gene expression profiles, which are caused by drugs are analysed.
Download to find out more.
Eurofins Genomics has introduced its good manufacturing practices (GMP) oligonucleotide offerings across Europe for in-vitro...
Eurofins Genomics is the first genomics service provider in Germany to achieve good laboratory practice...
Eurofins Genomics has announced a co-operation agreement with Igenbio to serve a worldwide market, by...
Eurofins Genomics, an international market leader in genomic services, has been accredited the ISO17025:2005 standard...